X
Roche, Blueprint raise pressure on Lilly with new Gavreto approval
https://pharmaphorum.com/news/roche-blueprint-raise-pressure-on-lilly-with-new-gavreto-approval/
thyroid cancer
NICE recommends funding for three thyroid cancer drugs
Eisai’s drug finally funded after two year delay
NICE rejects Bayer and Eisai drugs in thyroid cancer
Thyroid cancer drugs are available in Scotland and Wales
NICE wants to axe funding for two thyroid cancer drugs
NICE unconvinced by survival data from Ipsen and Sanofi drugs
Takeda preps for further acquisition
Japanese firm has set money aside for emerging markets M&A.
Eisai bemoans UK’s north-south cancer divide
Lenvima available in Scotland, not England.
Eisai angry over thyroid cancer drug impasse in England
Thyroid cancer drug falls through gap in NHS funding